Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999-2004.
about
Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopeniaSarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons--a narrative reviewSarcopenia and sarcopenic obesity: do they predict inferior oncologic outcomes after gastrointestinal cancer surgery?Impact of obesity and physical activity on functional outcomes in the elderly: data from NHANES 2005-2010The impact of waist circumference on function and physical activity in older adults: longitudinal observational data from the osteoarthritis initiative.The application of different appendicular skeletal muscle cutoff points and research definitions associated with health-related quality of life in Korean older people: data from KNHANES 2008-2011Association of Low Lean Mass With Frailty and Physical Performance: A Comparison Between Two Operational Definitions of Sarcopenia-Data From the Berlin Aging Study II (BASE-II).Impact of obesity on disability, function, and physical activity: data from the Osteoarthritis Initiative.Normal Weight with Central Obesity, Physical Activity, and Functional Decline: Data from the Osteoarthritis Initiative.Prevalence of sarcopenic obesity in Germany using established definitions: Baseline data of the FORMOsA study.Dynapenic obesity and the effect on long-term physical function and quality of life: data from the osteoarthritis initiativePrevalence of weakness and its relationship with limitations based on the Foundations for the National Institutes for Health project: data from the Health and Retirement Study.Body composition analysis by DXA (dual X-ray absorptiometry) in Brazilian men: normative data.Optimal nutrition and the ever-changing dietary landscape: a conference report.Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseasesSarcopenia and sarcopenic obesity in patients with muscular dystrophy.Challenges with the Medicare obesity benefit: practical concerns & proposed solutionsSarcopenia: burden and challenges for public health.Meal-based enhancement of protein quality and quantity during weight loss in obese older adults with mobility limitations: rationale and design for the MEASUR-UP trial.Searching for a relevant definition of sarcopenia: results from the cross-sectional EPIDOS studyGender-specific differences in the development of sarcopenia in the rodent model of the ageing high-fat rat.Weight Loss Interventions in Older Adults with Obesity: A Systematic Review of Randomized Controlled Trials Since 2005.Development of Novel Methods to Define Deficits in Appendicular Lean Mass Relative to Fat Mass.Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999-2004Predicting sarcopenia from functional measures among community-dwelling older adults.Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity studyLow Body Mass Index, Serum Creatinine, and Cause of Death in Patients Undergoing Percutaneous Coronary Intervention.The role of dietary protein intake in the prevention of sarcopenia of aging.Obesity misclassification and the metabolic syndrome in adults with functional mobility impairments: Nutrition Examination Survey 2003-2006The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action.Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review.Prevalence of Sarcopenic Obesity in Adults with Class II/III Obesity Using Different Diagnostic Criteria.Obesity-related inflammation: implications for older adults.Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?Muscle wasting in end-stage renal disease promulgates premature death: established, emerging and potential novel treatment strategies.Association of sarcopenic obesity with the risk of all-cause mortality: A meta-analysis of prospective cohort studies.Sarcopenic Obesity: An Appraisal of the Current Status of Knowledge and Management in Elderly People.Low Lean Mass With and Without Obesity, and Mortality: Results From the 1999-2004 National Health and Nutrition Examination Survey.Screening for muscle loss in patients established on peritoneal dialysis using bioimpedance.A pilot randomised controlled trial of a periodised resistance training and protein supplementation intervention in prostate cancer survivors on androgen deprivation therapy.
P2860
Q26743374-E0603CBE-D573-4B6A-8073-7BA3BBC3C92AQ26783216-9F51A0B0-1CE4-45CA-B61E-83FDED9007F4Q28079809-A67F91BD-76D1-48BF-AD52-2F54907C0EB3Q30830093-81A780A9-DE63-4995-A901-B9FB5E630FC1Q30841505-C3AD3DA8-D78D-43CF-AD7C-7DF9D0CE151BQ30881649-80410438-4BAE-4E7E-BF72-0BA988C22BB4Q30886859-19E6FE69-EFBD-418E-9C08-9A019A7E4015Q30974200-5C188D8E-1402-44A3-B00F-572BEA216E55Q30980332-AA8DF3D7-6497-48A4-BE89-EA7D1841BD25Q30990623-A69B9052-430C-40A8-A79C-B52FBDEC4854Q31003388-5B91E527-FAE3-48DB-AF9D-22597AF6430FQ31104351-B4C8CC45-FAA5-421E-BFB4-C9D6E442CCD3Q31142011-9E11273D-8C87-475D-8AC5-8606F29DBC48Q33720604-84B5DB0F-E121-4436-BD2B-D591CCA45A01Q34145591-51E89D27-4AC0-4C4B-B098-120DAB0B462BQ34299706-0F1053F3-31F1-4358-8C7B-6F415E2589DFQ34826129-1E418894-D9E6-41D1-9E2B-53453B1D3668Q35215893-7D45BF9C-EF78-4A02-AAF0-5A59524BBB80Q35626325-53AF2913-172F-433E-89C8-9089F29A52F8Q35690200-D351687C-BE98-4644-94C6-58C7691D5195Q35690211-11F8C519-9EE7-489C-AB54-E00C8A65C0C4Q36136769-34D7ACDB-79A4-4EA5-B103-2C7BA8AF98E6Q36159451-FF6ECB2D-9CE2-4CBC-B2DF-5A670110E7AFQ36781283-4F2E2A4F-6035-467D-A8B1-31299E45E919Q37219510-5FB06581-F329-4FDA-9419-7DD2E2506424Q37441579-A2D59D80-960C-4238-AA17-9AAEE39D4ED6Q37556047-4C0A980A-93EE-48C5-ADE9-AB1B540DC14EQ37591278-D8C796FA-2477-416B-97BD-7450F5FBFF79Q37603283-D81BD8A4-91A4-47B3-8F3D-F18ACDCE5DC8Q37647952-80BD063C-4E92-4710-B775-8C1A2C515C6CQ37675499-3A9B7A0C-BC1B-4990-AAD3-2978BB5930DBQ37737741-1D013319-F80D-4019-8CA2-8BFE3B8E5676Q38162295-5FE1CEC8-29BE-4792-812B-8A0B0AA56768Q38265681-8716FEB4-F5BA-4B11-B808-DFD052380F12Q38440818-C147AE04-3410-4AF7-A21C-3E9BDBCABDE2Q38566137-A7744765-A0D7-4A80-AB7F-A8DBDD6BF805Q38921272-27AE3125-E550-47FB-BE41-E70F854F36FBQ38957850-CFFF2D1A-ACB5-4DD6-9BC9-D7EE48AA129CQ39249156-581132A4-FE41-45E0-8F52-8B7D0DF78119Q39429406-A2307D7A-53E4-4A03-8A1F-77AC08AE9A11
P2860
Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999-2004.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Variation in the prevalence of ...... Examination Survey 1999-2004.
@ast
Variation in the prevalence of ...... Examination Survey 1999-2004.
@en
type
label
Variation in the prevalence of ...... Examination Survey 1999-2004.
@ast
Variation in the prevalence of ...... Examination Survey 1999-2004.
@en
prefLabel
Variation in the prevalence of ...... Examination Survey 1999-2004.
@ast
Variation in the prevalence of ...... Examination Survey 1999-2004.
@en
P2093
P2860
P356
P1476
Variation in the prevalence of ...... Examination Survey 1999-2004.
@en
P2093
Francisco Lopez-Jimenez
John A Batsis
Laura K Barre
Sarah I Pratt
Stephen J Bartels
Todd A Mackenzie
P2860
P304
P356
10.1111/JGS.12260
P407
P577
2013-05-06T00:00:00Z